Navigation Links
Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies

PALO ALTO, Calif., Aug. 18 /PRNewswire/ -- Based on its recent analysis of the personalized healthcare market, Frost & Sullivan presents ConforMIS with the 2008 North American Frost & Sullivan Award for Medical Device Healthcare Innovation. This recognition is in support of the company's unique commitment to delivering orthopedic implants that precisely fit each individual unlike traditional implants that require surgeons to shape patients' bones to fit standardized implants.

"The field of orthopedic implants is poised to transition towards personalized implants since off-the-shelf implant designs cannot accommodate all of the anatomic variations present across patients," explains Frost & Sullivan Research Analyst Archana Swathy. "ConforMIS is a pioneer, fueling this transition through the company's revolutionary technology platforms -- the iFit(TM) technology and iJig(TM) instrumentation."

While traditional orthopedic implants have undergone a long continuum of scaled developments to reach a certain level of sophistication, ConforMIS aims to revolutionize the very approach to implants through customization. Surgeries involving ConforMIS implants are minimally invasive, removing minimal bone and cartilage. This radical patient-specific initiative employs the proprietary "image-to-implant" technology platforms. The iFit technology transforms CT and MR imaging data into implants that are made to precisely fit the topography of the damaged joint. The same imaging data is utilized to create the iJig instrumentation, which are disposable patient-specific cutting and placement guides that help simplify the surgical process and improve surgical outcomes and efficiency.

The image-to-implant technology platforms ensure optimal implant fit and alignment, while offering complete coverage of weight-bearing surfaces. ConforMIS implants also offer thorough coverage of the cortical rim on the tibia, which minimizes the risk of subsidence and loosening, which are often observed with traditional implants.

Noteworthy milestones for ConforMIS have included FDA clearance for the iUni(TM) uni-compartmental resurfacing system and for the iDuo(TM) bi-compartmental resurfacing system. These patient-specific, partial knee resurfacing systems treat arthritic damage confined to one or two compartments of the knee. The iUni and the iDuo represent novel approaches to early intervention, using a personalized approach not previously available in orthopedics. The launch of these pioneering products demonstrate ConforMIS's dedication to revolutionizing the joint-replacement industry. ConforMIS has one other product already in commercialization in the United States and Europe: the iForma(TM) knee interpositional device. The company plans to release the iTotal tri-compartmental knee resurfacing system in 2009.

Due to the simplicity of the surgical procedures, ConforMIS's surgeon training utilizes an online model and allows for unusually rapid movement down the learning curve. ConforMIS also aims to conduct post-approval studies that can help evaluate and establish the long term efficacy of its products.

ConforMIS has entered a new dimension in advancing the scope of orthopedic implants," states Swathy. "Through the unique patient-specific approach, the company is able to target patients who benefit from early medical intervention and for whom a traditional total knee replacement would be too invasive."

Addressing this distinctive patient pool with its novel technology creates an opportunity to expand the market for joint implants. The technology provides a less-invasive alternative that maintains options for other, future surgical treatments. It is this commitment to improving patients' quality of life and helping surgeons serve patients more effectively that makes ConforMIS a deserving recipient of the 2008 Frost & Sullivan Medical Device Healthcare Innovation Award for personalized/customized care.

Each year, Frost & Sullivan presents this award to the company that has introduced truly innovative products, practices, or ideas to the specified industry or segment. The company's innovative contribution(s) to healthcare make it possible to envision a new level of care in the diagnosis, treatment, and management of disease, leading to better outcomes and quality-of-life for patients. In addition, the company's innovative efforts may also lead to improvements in the tools that clinicians, diagnosticians, researchers, and healthcare administrators have at their disposal to improve quality and efficiency in provision of healthcare services.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About ConforMIS

ConforMIS, Inc. is a privately held company that develops and commercializes medical devices for the treatment of osteoarthritis and joint damages. The Company's novel and scaleable 'image-to-implant' process is comprised of two related technology platforms. iFit(TM) Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient's anatomy. iJig(TM) Instrumentation enables the creation of disposable, easy-to-use instrumentation that simplifies the surgical process and improves reproducibility.

To date, ConforMIS has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of osteoarthritis. Each of these devices has been cleared by the US Food and Drug Administration for marketing in the U.S. For more information, visit

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit


Jake Wengroff


SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
2. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
3. Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award
4. Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy
5. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
6. Therapy Could Save Limbs After Frostbite
7. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
8. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
9. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
10. MedApps Receives Prestigious Frost & Sullivan Award
11. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
Post Your Comments:
(Date:11/24/2015)... ... ... Autism Speaks, the world’s leading autism science and advocacy organization, will take ... of people around the world. On December 1, supporters can make an online donation ... the personal stories behind those gifts. , Just as Black Friday and Cyber-Monday ...
(Date:11/24/2015)... Tennessee (PRWEB) , ... November 24, 2015 , ... ... Pharmacy Quality Trend Report . Throughout the past year there have been multiple breakthroughs ... mature state. During this transition, PharmMD has enabled their customers and partners to stay ...
(Date:11/24/2015)... ... ... am so thrilled, as a newbie here, to leave a mark for the entire staff,” ... Makeover® from California Casualty . Stephanie is in her fifth year teaching at Santan ... , “This is such an amazing school and we deserve a space where we can ...
(Date:11/24/2015)... ... November 24, 2015 , ... Add a fresh touch to ... easy and affordable way to bring long-lasting style and cheer to any space. , ... clean the air and keep on giving all year long. , “Holiday plants make ...
(Date:11/24/2015)... ... November 24, 2015 , ... Tudore Tranquility is a new restaurant in Tokyo, ... plant-based fine dining menu that is full of flavorful and creative dishes that exceed ... wedding dinner or a small intimate event. The décor looks stunning with gold and ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 --> ... "Spine Biologics Market by Product Type (Bone Graft, Bine Graft ... and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography ... market was valued at $1.90 Billion in 2014 and is ... of 4.4% during the forecast period of 2015 to 2020. ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
(Date:11/24/2015)... 2015  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... Directors has declared a special 1 percent stock dividend on ... December 14, 2015, to shareholders of record December 7, 2015.  ... shares of common stock. --> ... strong endorsement of our confidence in Ascendant,s growth strategy as ...
Breaking Medicine Technology: